These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6753054)

  • 1. [Marcescinotype and biotype as epidemiologic markers in Serratia infection].
    Domínguez Rojas V; Conde Herrera M; Rey Calero J; Carrasco de la Peña JL; Múgica López N
    Rev Clin Esp; 1982 May; 165(4):255-7. PubMed ID: 6753054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serratia marcescens as an opportunistic human pathogen].
    Yokota M; Okazawa A; Tanaka T
    Nihon Saikingaku Zasshi; 2001; 56(3):527-35. PubMed ID: 11577410
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serratia marcescens infections.
    Acar JF
    Infect Control; 1986 May; 7(5):273-8. PubMed ID: 3519496
    [No Abstract]   [Full Text] [Related]  

  • 7. Serratia marcescens causing hospital-acquired lower respiratory tract infection.
    Byrne AH; Boyle B; Herra CM; Hone R; Keane CT
    J Hosp Infect; 2000 Jul; 45(3):242-4. PubMed ID: 10896806
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ecological behavior of Klebsielleae].
    Fritsche D; Spieckermann C; Dostal C
    Med Klin; 1972 Sep; 67(39):1246-9. PubMed ID: 4565309
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of non-fermenting gram negative bacilli and specially Serratia marcescens in respiratory infections in humans].
    Dzierzanowska D; Boroń-Kaczmarska A
    Gruzlica; 1974 Oct; 42(10):975-9. PubMed ID: 4607872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Distribution of clinical isolates of Serratia marcescens by bacteriocin typing: a comparison of bacteriocin types between two distant university hospitals].
    Nasu M; Goto J; Goto Y; Tashiro T; Itoga T; Yamaguchi K
    Kansenshogaku Zasshi; 1984 Apr; 58(4):312-7. PubMed ID: 6434655
    [No Abstract]   [Full Text] [Related]  

  • 11. Infections caused by nonpigmented Serratia. Report of seven cases.
    Magnuson CW; Elston HR
    Ann Intern Med; 1966 Sep; 65(3):409-18. PubMed ID: 5330144
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study on the epidemiology of Sarratia marcescens using bacteriocin typing].
    Fritsche D; Dostal C; Spieckermann C
    Zentralbl Bakteriol Orig A; 1973 May; 223(4):513-9. PubMed ID: 4146827
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):521-7. PubMed ID: 779357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outbreak of Serratia marcescens, and its control.
    Cabrera HA
    Arch Intern Med; 1969 Jun; 123(6):650-5. PubMed ID: 4890440
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on group A (phage tail) bacteriocins of Serratia marcescens. VI. Calcium ion-dependent biological activity of subgroup II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):528-35. PubMed ID: 779358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
    Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
    Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serovar and antibiotic-sensitivity of Serratia marcescens isolated from urinary tract infections].
    Okuda T; Hirosawa Y; Enda N; Zenyoji H
    Kansenshogaku Zasshi; 1984 Jun; 58(6):483-90. PubMed ID: 6436403
    [No Abstract]   [Full Text] [Related]  

  • 18. State of the art: typing of Serratia marcescens.
    Pitt TL
    J Hosp Infect; 1982 Mar; 3(1):9-14. PubMed ID: 6177740
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiological markers of Serratia marcescens isolates causing nosocomial infections in Spain (1981-1991).
    Boquete T; Vindel A; Martin-Bourgon C; Azañedo L; Sáez-Nieto JA
    Microbiologia; 1996 Dec; 12(4):607-12. PubMed ID: 9018695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of a single source nursery epidemic due to Serratia marcescens.
    McCormack RC; Kunin CM
    Pediatrics; 1966 May; 37(5):750-5. PubMed ID: 5326773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.